What technology areas does Institut National De La Sante Et De La Rech Medicale (Inserm) patent most?

Top mapped technology areas by patent count: Human Necessities (19); Chemistry & Metallurgy (18); Physics (9).

Is Institut National De La Sante Et De La Rech Medicale (Inserm)'s patent activity growing?

In our data, assignee counts were 4 in 2018 and 9 in 2020 (higher year over year).

What are recent patents assigned to Institut National De La Sante Et De La Rech Medicale (Inserm)?

See the “Recent patents” section above for the latest 5 publications we attribute to this assignee.

Institut National De La Sante Et De La Rech Medicale (Inserm) patents

Institut National De La Sante Et De La Rech Medicale (Inserm) holds 23 patents in our database, with recent filings and technology areas summarized below.

Company patent statistics
Metric	Value
Total patents	23
Recent patents	0
First publication	Nov 14, 2017
Latest publication	Aug 27, 2020

Filing trend

Year-over-year patent counts for this assignee.

Filing activity appears to be growing based on the most recent years.

Patents filed per year
Year	Patents
2017	10
2018	4
2020	9

Browse patents by year
Year	Patents
2017	10
2018	4
2020	9

Recent patents

Latest publications where this party is an assignee.

Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy
US-2020268859-A1 · Aug 27, 2020 · US
Lentiviral vectors for regulated expression of a chimeric antigen receptor molecule
US-10752668-B2 · Aug 25, 2020 · US
Process for Detecting Nucleic Acid Molecules by Magnetic Hyperthermia and Assembly Enabling Such Detection
US-2020263241-A1 · Aug 20, 2020 · US
Ptgdr-1 and/or ptgdr-2 antagonists for preventing and/or treating systemic lupus erythematosus
US-2020261413-A1 · Aug 20, 2020 · US
Process for multi-analyses of rare cells extracted or isolated from biological samples through filtration
US-2020264166-A1 · Aug 20, 2020 · US

Notable patents

Representative or frequently cited publications from precomputed assignee stats.

Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy
US-2020268859-A1 · Aug 27, 2020 · US
Lentiviral vectors for regulated expression of a chimeric antigen receptor molecule
US-10752668-B2 · Aug 25, 2020 · US
Process for Detecting Nucleic Acid Molecules by Magnetic Hyperthermia and Assembly Enabling Such Detection
US-2020263241-A1 · Aug 20, 2020 · US
Ptgdr-1 and/or ptgdr-2 antagonists for preventing and/or treating systemic lupus erythematosus
US-2020261413-A1 · Aug 20, 2020 · US
Process for multi-analyses of rare cells extracted or isolated from biological samples through filtration
US-2020264166-A1 · Aug 20, 2020 · US

Technology areas

Mapped technology topics for this assignee.

Company technology slices
Technology	Patents
Human Necessities	19
Chemistry & Metallurgy	18
Physics	9
Operations & Transport	2
Cross-Sectional Technologies	2

Frequently asked questions

Answers are generated from the same data shown on this page.

How many patents does Institut National De La Sante Et De La Rech Medicale (Inserm) have in patentsdb?: Institut National De La Sante Et De La Rech Medicale (Inserm) is linked to 23 publications as assignee in our database.
What technology areas does Institut National De La Sante Et De La Rech Medicale (Inserm) patent most?: Top mapped technology areas by patent count: Human Necessities (19); Chemistry & Metallurgy (18); Physics (9).
Is Institut National De La Sante Et De La Rech Medicale (Inserm)'s patent activity growing?: In our data, assignee counts were 4 in 2018 and 9 in 2020 (higher year over year).
What are recent patents assigned to Institut National De La Sante Et De La Rech Medicale (Inserm)?: See the “Recent patents” section above for the latest 5 publications we attribute to this assignee.